Results 181 to 190 of about 116,120 (219)
Unpacking gender wage inequality in poultry farming: evidence from Togo through Oaxaca-Blinder analysis. [PDF]
Ihou AFY +4 more
europepmc +1 more source
Abstract Caste—an ascriptive social hierarchy in South Asia and its diaspora—is a globalized phenomenon. Recent caste‐based discrimination, particularly in technology companies and anti‐caste efforts to address it, has compelled academia, policy, and the technology industry to better understand contemporary mechanics of caste.
Nayana Kirasur, Britt Paris
wiley +1 more source
Knowing better, doing better: Taking stock of the UN Agenda 2030, its means, its progress, and its shortfalls. [PDF]
Sota R, Kammen DM, Klemun M, Venghaus S.
europepmc +1 more source
Abstract The issue of inequality caused by algorithms, termed ‘algorithmic inequality’, has recently attracted scholarly attention in many disciplines due to its profound implications for society. While the body of literature on algorithmic inequality has grown, there remains a lack of comprehensive understanding of its nature, drivers, and impact ...
Shiwei Jia, Jia Tina Du, Hui Yan
wiley +1 more source
Retraction Note: COVID-19 Crisis Impact on the Stability Between Parties in Crowdfunding and Crowdsourcing. [PDF]
Liu ZJ +3 more
europepmc +1 more source
Small and mid‐sized pharmaceutical innovators often have limited in‐house health economics and market access expertise, and may struggle to align development strategies of investigational medicinal products with health system needs and payer expectations.
Zoltán Kaló +5 more
wiley +1 more source
Comment on "Privacy-preserving multicenter validation of the RMODscore". [PDF]
Sengan S, Mamazulunov N, Khujamkulova I.
europepmc +1 more source
Early‐stage health technology assessment of a curative gene therapy for multiple sclerosis
Aims Multiple sclerosis (MS) is associated with significant early morbidity, reduced life expectancy and substantial healthcare and societal costs. The primary objective of this study is to assess the early cost‐effectiveness potential of a novel gene therapy, IMMUTOL, for MS compared with current high‐efficacy treatment sequences.
Attila Imre, Balázs Nagy, Rok Hren
wiley +1 more source
Beyond benchmarking: Using WHO's NPHA capability framework as a driver of institutional reform. [PDF]
Namara G +4 more
europepmc +1 more source
Cost–benefit analysis of screening programme for diabetic retinopathy in Bulgaria
Aims Late‐diagnosed diabetic retinopathy (DR) is difficult and expensive to treat. Screening programmes can identify the disease early and reduce the costs of its future treatment. This study aims to analyse the cost–benefit of screening programmes for DR.
Iva Nenkova +5 more
wiley +1 more source

